CIFoundry
Back to Catalog
Neurology
FDA cleared
Epitel

Last reviewed Nov 10, 2026 against the sources listed on this page · How we review

At a glance

REMI-AI is Epitel's seizure detection software for its REMI wearable EEG sensors, flagging possible seizures in remote and in-hospital EEG recordings for clinician review.

FDA:
510(k) K243185 +4 more
Epic:
Not on record
Named users:
Not on record
Published study:
Not on record

Description

REMI-AI is Epitel's seizure detection software for its REMI wearable EEG sensors, flagging possible seizures in remote and in-hospital EEG recordings for clinician review.

FDA-clearedEEGSeizure detectionWearable EEG

Quick answers

Answered only from the sourced records on this page. Questions we can't answer from the record are left out. How we review

Is REMI-AI FDA cleared?
The public FDA database has 5 records that our team matched to REMI-AI. The most recent is 510(k) K243185 (REMI Remote EEG Monitoring System), decided Mar 2025. Check that the cleared use matches how you plan to use it.FDA record K243185

Security & contracting

The maker has not reported these details yet. Ask the vendor directly during evaluation.

Workflow stage
Not reported
Integrations
Not reported
Data inputs
Not reported
Deployment
Not reported
Signs a BAA
Not reported
SOC 2 report
Not reported
HITRUST
Not reported
Evidence type
Not assessed

Readiness details are self-reported by the maker and are not checked by Clinical Intelligence Foundry. Evidence type describes the kind of study or document the listing links to; it is not a rating or endorsement. Confirm compliance documents with the vendor before purchase.

Who's using this

Organizations named in public announcements or by the developer. Inclusion is not an endorsement.

No public deployments found yet. Using this tool? The maker can claim the listing to add customers.

Get weekly updates for Neurology

Up to 5 new items a week: new tools, FDA decisions and studies. Newest first, never ranked. Confirm by email, unsubscribe any time.

Sources

This listing links to primary sources. Follow the links below to check details directly with the developer, regulator or publication.

Website

FDA database records

  • K243185 · 510(k) · Mar 2025
    REMI Remote EEG Monitoring System
  • K240408 · 510(k) · Oct 2024
    REMI-AI Rapid Detection Module (REMI-AI RDM)
  • K231779 · 510(k) · Jan 2024
    REMI AI Discrete Detection Module
  • K230933 · 510(k) · Jun 2023
    REMI Remote EEG Monitoring System
  • K203827 · 510(k) · Mar 2021
    REMI

Matched by our team from the public FDA database; checked Nov 10, 2026.

History (6)Show

Dated events on this listing's public record, newest first.

  1. Nov 10, 2026

    Added to CIFoundry

  2. Mar 21, 2025

    FDA 510(k) K243185 decision datesource

  3. Oct 17, 2024

    FDA 510(k) K240408 decision datesource

  4. Jan 3, 2024

    FDA 510(k) K231779 decision datesource

  5. Jun 30, 2023

    FDA 510(k) K230933 decision datesource

  6. Mar 29, 2021

    FDA 510(k) K203827 decision datesource

Developer

Epitel

Evaluating this tool?

Get a printable packet for your committee: what the public record shows, the gaps to raise with the vendor, and the questions for this kind of tool.

Prepare evaluation packet

Checklist for your role: Admin · Physician · IT · Compliance

Compare similar tools →

Own this tool?

Claim this listing to update its details and connect with your audience.